Corporate Partners

Finally, a solution to 10X your revenue without relying on noneffective traditional advertising by Implementing this proven 3 step formula that reaches, attracts & converts more qualified prospects regardless if you’re selling a Cash or Insurance based service/ product. We will show you how to ethically and legally siphon the hottest prospects right from the lobby of our biggest competitors while Increasing profitability by implementing our backend optimizer. All this and more…

This webinar will consist of
A.) Scientific overview of amniotic tissue products.
B.) Amniotic wound care presentation.
C.) Reimbursement process required for reimbursement

NOTE: Date Change (start time is the same).

Finally, a solution to 10X your revenue without relying on noneffective traditional advertising by Implementing this proven 3 step formula that reaches, attracts & converts more qualified prospects regardless if you’re selling a Cash or Insurance based service/ product. We will show you how to ethically and legally siphon the hottest prospects right from the lobby of our biggest competitors while Increasing profitability by implementing our backend optimizer. All this and more…

As the national leader in Hands-on Regenerative Therapy Training courses, R3 Medical has added Autologous Adipose SVT Training to all upcoming regenerative training courses. The SVT autologous adipose procedures are effective, safe, FDA compliant, and taught with real procedures on real patients! In this Webinar, David Greene, MD, MBA, of R3 Medical Training discusses why adipose is critical for regenerative providers to learn in the evolving landscape of US regenerative therapies. Adipose trainer Dr. Sabrina Solt will review the procedure and explain the techniques being taught!

Join neuroscientist and inventor, Dr. Dayan Goodenowe as he shares how his patented blood testing technology, which measures thousands of biochemicals in the blood, made it possible for him to discover and identify the deficiency of a critical brain nutrient called plasmalogens in persons diagnosed with Alzheimer’s disease. From this patented discovery Dr. Goodenowe, designed, developed, and patented three separate metabolic precursor technologies to selectively target and restore blood plasmalogen levels. Dr. Goodenowe has now developed and released 100% natural versions of his patented precursors as dietary supplements. Since the unique chemical structure of plasmalogens causes them to be broken down in the stomach before they can be absorbed into the blood, Dr Goodenowe’s supplements are the only scientifically proven way to increase blood plasmalogens. Since his initial discovery of deficient plasmalogens in dementia, Dr. Goodenowe has collaborated with leading disease and population health experts from around the world involving tens of thousands of patients. These studies have revealed that the negative consequences of low blood plasmalogens go way beyond just dementia to include other neurological diseases such as bipolar disorder and schizophrenia, cancer, and all-cause mortality. Plasmalogens make up approximately 20% of all the lipids in the brain and up to 35% of the lipids in the heart and are found in high concentrations in the eyes, lungs, and kidneys as well. Having low plasmalogens is just not worth the risk. This is the emerging topic of the year that you don’t want to miss and you are hearing it from the world’s leading expert.

As the national leader in Hands-on Regenerative Therapy Training courses, R3 Medical has added Autologous Adipose SVT Training to all upcoming regenerative training courses. The SVT autologous adipose procedures are effective, safe, FDA compliant, and taught with real procedures on real patients! In this Webinar, David Greene, MD, MBA, of R3 Medical Training discusses why adipose is critical for regenerative providers to learn in the evolving landscape of US regenerative therapies. Adipose trainer Dr. Sabrina Solt will review the procedure and explain the techniques being taught!

Join neuroscientist and inventor, Dr. Dayan Goodenowe as he shares how his patented blood testing technology, which measures thousands of biochemicals in the blood, made it possible for him to discover and identify the deficiency of a critical brain nutrient called plasmalogens in persons diagnosed with Alzheimer’s disease. From this patented discovery Dr. Goodenowe, designed, developed, and patented three separate metabolic precursor technologies to selectively target and restore blood plasmalogen levels. Dr. Goodenowe has now developed and released 100% natural versions of his patented precursors as dietary supplements. Since the unique chemical structure of plasmalogens causes them to be broken down in the stomach before they can be absorbed into the blood, Dr Goodenowe’s supplements are the only scientifically proven way to increase blood plasmalogens. Since his initial discovery of deficient plasmalogens in dementia, Dr. Goodenowe has collaborated with leading disease and population health experts from around the world involving tens of thousands of patients. These studies have revealed that the negative consequences of low blood plasmalogens go way beyond just dementia to include other neurological diseases such as bipolar disorder and schizophrenia, cancer, and all-cause mortality. Plasmalogens make up approximately 20% of all the lipids in the brain and up to 35% of the lipids in the heart and are found in high concentrations in the eyes, lungs, and kidneys as well. Having low plasmalogens is just not worth the risk. This is the emerging topic of the year that you don’t want to miss and you are hearing it from the world’s leading expert.